What are the main advantages of contracting with RUSSLAN for pharmaceutical, biotechnology and device companies?
In a nutshell, these are cost and time. We fully understand the financial burden associated with conducting clinical trials for pharmaceutical, biotechnology and device companies. Therefore, cost-effective conduct of clinical trials for our clients is one of our highest priorities. We have full confidence that the cost of our services is among most competitive in Europe and worldwide. This is achieved due to two factors – firstly, lean and flat structure of RUSSLAN with very low overheads, and secondly, the rational choice of clinical trial sites. Typically we work with the clinical trial sites located in Eastern European countries that can deliver affordable clinical trials quickly – but without any compromises on quality. The shortest possible time to market is another crucial factor for our clients. We have established systems that allow us to avoid delays in regulatory approvals process, and our experts armed with full knowledge of the clinical trial environment in our countries of
